to construct 3 categories of mammogram history: (1) never had a mammogram, (2) had over a year ago, and (3) had less than a year ago. We tested for differences in importance evaluations by mammogram history using ordered logit regression. Analyses applied the GfK survey weights to adjust for nonresponse bias and panel nonresponse to produce nationally-representative estimates. The study was determined to be exempt from review by the University of Minnesota institutional review board.
Discussion | Women are more aware of the benefits of mammography screening than the harms, and women who have recently undergone mammography are more likely to judge these benefits as important. This may be owing to a lack of balanced information from physicians, 5 public health officials, news media, and disease advocacy groups that have long emphasized screening's benefits. Our findings suggest that there are opportunities for targeted education and communication at both the general public and individual levels, with a focus on educating women on the harms of screening, which they are much more likely to experience than benefits. However, the fact that women are predisposed to consider benefits as more important than harms poses a challenge to informed decision making about screening, suggesting the need for new paradigms in communicating the cumulative risks of the benefits and harms. This analysis includes 25 clinicians and 25 patients with visits after a fully-functional EHR was implemented. Research assistants video recorded visits 3 to 16 months (median, 9) after the implementation of the EHR. After visits, patients rated recent quality of care (poor to excellent). All participants provided written informed consent and received $5 to $20 gift cards for each study procedure. The University of California, San Francisco, institutional review board approved the study. Two researchers (N.R. and G.Y.M.) coded visits using mutually exclusive categories (Figure) : multitasking EHR use (while clinician or patient spoke); silent EHR use (≥3-second silence); non-EHR multitasking; silent non-EHR tasks; education with EHR; education with paper; physical examination; and focused patient-clinician talk. For each category, we calculated total proportion of visit time and sample medians (interquartile ranges).
We qualitatively coded EHR tasks conducted silently and communication transitioning into and out of silent EHR use. We compared patients rating care as "excellent" after visits above and below median multitasking EHR use, using generalized estimating equations regression.
Results | Among 35 visits between 25 patients and 25 clinicians, 17% were in Spanish and 40% of relationships were longer than 5 years (Table) . Median visit length was 20.6 minutes.
The Table shows Patients rated care "excellent" after 66.7% of lowmultitasking EHR use visits and 76.5% of high-multitasking EHR visits (P = .65).
Silent EHR use (n = 193 instances) occurred while clinicians viewed (39.4%) or entered (24.4%) information, prescribed (13.5%), reconciled medications (8.3%), arranged appointments (5.2%), ordered tests or referrals (5.2%), and sought or typed patient education (3.1%). The median silent EHR use lasted 16.2 seconds, shortest for viewing information (4.6) and longest for patient education (34.0).
Qualitative analysis revealed that clinicians demonstrated various transitions into silent EHR use. Sometimes clinicians signaled a need to focus ("Give me a minute, I want to review in the computer what we've done before."). Other times, clinicians shifted into silence without warning ("There aren't specific treatments...but they're going to...uh...uh...uh...").
Patients often broke silent EHR use with small talk ("So, how is your family?"), or by introducing concerns ("Oh yea, what did the x-ray show about my shoulder?"). Multitasking EHR use indicates clinicians used EHR while clinicians or patients spoke; silent EHR use, clinicians used EHR in silences for longer than 3 seconds; non-EHR multitasking, clinicians completed non-EHR tasks while clinicians or patients spoke; silent non-EHR tasks, clinicians completed non-EHR tasks in silences longer than 3 seconds; education with EHR, clinicians used EHRs to counsel patients; education with paper, clinicians used paper to counsel patients; physical examination, clinicians examined patients; focused patient-clinician talk, clinicians and patients spoke with no clinician tasks. burdens. 6 However, clinicians must attend to emerging patient concerns and decide whether to address those concerns, defer them to complete EHR tasks safely, or attempt to complete both, despite multitasking risks.
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Limitations include sample size, single setting, timeframe after implementation, and lack of clinical outcomes. Study strengths are inclusion of a diverse provider and patient population.
Conclusions | Studies should explore strategies for negotiating multitasking and silent EHR use, engaging patients "actively" during silent EHR use, and ensuring clinicians detect emerging patient concerns. 
Injurious Falls and Syncope in Older Community-Dwelling Adults Meeting Inclusion Criteria for SPRINT
The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that treating adults 75 years of age or older with hypertension to reach a systolic blood pressure target of less than 120 mm Hg compared with a systolic blood pressure target of less than 140 mm Hg reduced the numbers of cardiovascular events and death without a significant increase in the number of injurious falls or syncope. 1 However, prior to the adoption of an intensive strategy to lower systolic blood pressure in the oldest segment of the population, it is prudent to determine if individuals meeting inclusion criteria for SPRINT outside the clinical trial context are similar to trial participants, especially with regard to risk for adverse outcomes. We used The Irish Longitudinal Study on Ageing 2,3 (TILDA) to compare baseline rates of injurious falls and syncope in community-dwelling older adults with the rates in the standard care group of SPRINT.
Methods | The Irish Longitudinal Study on Ageing is a nationally representative prospective cohort study of communitydwelling adults 50 years of age or older in the Republic of Ireland. We used the SPRINT eligibility criteria to identify TILDA participants who would be eligible for the trial. 1, 4 ; all SPRINT eligibility parameters apart from degree of proteinuria were available for TILDA participants. Falls and syncope were assessed either by self-report or proxy at each wave. Participants were asked if they had fallen since their last interview and, if so, if they injured themselves seriously enough to need medical treatment. These questions were repeated for syncope. All analyses were performed using R statistical software (R Foundation for Statistical Computing) and Stata, version 14.1 (StataCorp), incorporating inverse probability weighting to account for complex survey designs. P < .05 was considered significant. Table  5 displays a comparison of characteristics between TILDA participants meeting inclusion criteria for the subgroup of SPRINT participants who were 75 years of age or older and those of participants in the standard care arm of SPRINT.
Results | The
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